Pharmacological management of pain in chronic wounds and stomas in adult patients
Main Article Content
Keywords
Pain, Wounds and Injuries, Ostomy, Analgesia, Pain Management
Abstract
Abstract
Pain associated with chronic wounds and stomas is a frequent and complex clinical problem that is often underestimated and undertreated. Its pathophysiology is multifactorial, since it combines nociceptive, inflammatory, and neuropathic mechanisms, which justifies the need for a comprehensive, multimodal pharmacological approach. This review critically analyzes recent evidence on systemic, topical, and adjuvant treatments used for the management of baseline pain, procedure-related pain, neuropathic pain, and breakthrough pain in patients with chronic wounds or stomas. Systematic reviews, clinical trials, and clinical practice guidelines published over the past 5 years were included. Non-opioid analgesics and opioids remain as the cornerstone of pharmacological treatment; however, their effectiveness may be limited when neuropathic components are unrecognized or poorly characterized. Topical formulations of local anesthetics, opioids, and emerging agents have demonstrated benefits, particularly in pain associated with wound care and local procedures. Likewise, gabapentinoids and dual-action antidepressants are effective in the management of neuropathic pain, while rapid-onset opioids may be considered for breakthrough pain in selected clinical contexts. Although the available evidence is heterogeneous, it supports an individualized approach that integrates different mechanisms of action and considers wound or stoma characteristics, patient comorbidities, and clinical safety aspects.
References
1. Redmond MC, Desmond J, Griffin M, et al. Chronic wound pain: a systematic review of its epidemiology, mechanisms, and impact. J Wound Care. 2025;34(1):26-35. doi: 10.12968/jowc.2025.34.1.26
2. Berger V, Gahide I, Fouassier D. Pharmacological strategies for pain management in chronic wounds. Eur J Clin Pharmacol. 2024;80:125-136. doi: 10.1007/s00228-023-03630-y
3. Sabah L, Robertson K, Bendewald MJ. Advances in topical analgesics for wound-related pain. Pain Pract. 2025;25(2):155-66. doi: 10.1111/papr.13115
4. Ffrench C, Power J, O’Connor T. Chronic wound pain: under-recognised and undertreated. Pain Rep. 2023;8(5):e1073. doi: 10.1097/PR9.0000000000001073
5. Lee K, Lee S, Kim J. Wound pain management: the present and the future. J Wound Manag Res. 2024;20(3):199-211. doi: 10.22467/jwmr.2024.03153
6. Kaye AD, Kaye AM, Manchikanti L, et al. Emerging pharmacologic strategies for neuropathic pain in chronic wound patients. Medicina (Kaunas). 2025;61:1063. doi: 10.3390/medicina6101063
7. Ivory JD, Finn DP, Vellinga A, et al. Topical adjuncts for chronic wound pain: a systematic review protocol. HRB Open Res. 2022;5:58. doi: 10.12688/hrbopenres.13519.1
8. Kim JS, Lee JH, Park SC. Pain characteristics and management in stoma patients: a narrative review. Ann Coloproctol. 2024;40(4):255-64. doi: 10.3393/ac.2023.00717.0144
9. Baethge C, Goldbeck-Wood S, Mertens S. SANRA: a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019;4:5. doi: 10.1186/s41073-019-0064-8
10. Aromataris E, Munn Z, eds. JBI Manual for Evidence Synthesis. Adelaide (AU): Joanna Briggs Institute; 2020.
11. Greenhalgh T, Thorne S, Malterud K. Time to challenge the spurious hierarchy of systematic over narrative reviews? Eur J Clin Invest. 2018;48(6):e12931. doi: 10.1111/eci.12931
12. Woo K. Chronic wound pain: mechanisms and clinical implications. Wound Repair Regen. 2021;29(3):495-503. doi: 10.1111/wrr.12897
13. Ahn S, Lee Y, Kim H. Inflammatory mediators and pain in chronic wounds. J Pain Res. 2022;15:1237-49. doi: 10.2147/JPR.S360882
14. Attal N, Martinez V, Bouhassira D. Mechanisms of neuropathic pain and therapeutic implications. Lancet Neurol. 2021;20(3):215-26. doi: 10.1016/S1474-4422(20)30446-6
15. D’Ambrosio F, Pappalardo C, Scardigno A, et al. Peristomal skin complications in ileostomy and colostomy patients: what we need to know from a public health perspective. Int J Environ Res Public Health. 2023;20(1):79. doi: 10.3390/ijerph20010079
16. Rosenberger DC, Pogatzki-Zahn EM. Chronic post-surgical pain: update on incidence, risk factors and preventive treatment options. BJA Educ. 2022;22(5):190-6. doi:10.1016/j.bjae.2021.11.008
17. Healy CR, Gethin G, Pandit A, et al. Chronic wound-related pain, wound healing and the therapeutic potential of cannabinoids. Biomed Pharmacother. 2023;168:115714. doi: 10.1016/j.biopha.2023.115714
18. Nosek K, Leppert W, Puchała Ł, et al. Efficacy and safety of topical morphine: a narrative review. Pharmaceutics. 2022;14(7):1499. doi: 10.3390/pharmaceutics14071499
19. Selva C, Fernández-Ginés FD, Cortiñas-Sáenz M, et al. Cost-effectiveness of domiciliary topical sevoflurane for painful leg ulcers. PLoS One. 2021;16(9):e0258154. doi: 10.1371/journal.pone.0258154
20. Santana LS, Nunes MLG, Santos VLCG. Prevalence of peristomal dermatitis-related pain: a cross-sectional study. Pain Manag Nurs. 2025;26(6). doi:10.1016/j.pmn.2025.04.014
21. Colloca L, Ludman T, Bouhassira D, et al. Neuropathic pain. Nat Rev Dis Primers. 2024;10:14. doi: 10.1038/s41572-024-00463-0
22. Lee K, Lee S. Topical and systemic analgesia for wound care: current perspectives. J Wound Manag Res. 2024;20(3):145-54. doi: 10.22467/jwmr.2023.02117
23. Attal N, Bouhassira D. Pharmacologic treatments for neuropathic pain. Lancet Neurol. 2021;20(6):465-76. doi: 10.1016/S1474-4422(21)00073-0
24. Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114(1-2):29-36. doi: 10.1016/j.pain.2004.12.010.
25. Freynhagen R, Baron R, Gockel U, et al. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006;22(10):1911-20. doi: 10.1185/030079906X132488
26. Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain. 2001;92(1-2):147-57. doi: 10.1016/s0304-3959(00)00482-6
27. Mao P, Zhang Y, Liu B, et al. Effect and safety profile of topical lidocaine on post-surgical neuropathic pain and quality of life: a systematic review and meta-analysis. J Clin Anesth. 2024;92:111219. doi: 10.1016/j.jclinane.2023.111219
28. Riccardi A, Guarino M, Serra S, et al. Narrative review: low-dose ketamine for pain management. J Clin Med. 2023;12(9):3256. doi: 10.3390/jcm12093256
29. Daud ML, Simone GG. Management of pain in cancer patients - an update. Ecancermedicalscience. 2024;18:1821. doi: 10.3332/ecancer.2024.1821
30. Mercadante S. Once again… breakthrough cancer pain: an updated overview. J Anesth Analg Crit Care. 2023;3(1):23. doi:10.1186/s44158-023-00101-x
31. Bossi P, Escobar Y, Pea F. Rapid-Onset Opioids for Management of Breakthrough Cancer Pain: Considerations for Daily Practice. Front Pain Res. 2022;3:893530.
32. Alorfi NM. Pharmacological methods of pain management: narrative review of medication used. Int J Gen Med. 2023;16:3247-56. doi: 10.2147/IJGM.S419239
33. Freo U, Ruocco C, Valerio A, et al. Paracetamol: a review of guideline recommendations. J Clin Med. 2021;10(15):3420. doi: 10.3390/jcm10153420
34. Da Costa BR, Pereira TV, Saadat P, et al. Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis. BMJ. 2021;375. doi: 10.1136/bmj.n2321
35. Busse JW, Wang L, Kamaleldin M, et al. Opioids for Chronic Noncancer Pain: A Systematic Review and Meta-analysis. JAMA. 2018;320(23):2448-60. doi: 10.1001/jama.2018.18472
36. Finnerup NB, Kuner R, Jensen TS. Neuropathic Pain: From Mechanisms to Treatment. Physiol Rev. 2021;101(1):259-301. doi: 10.1152/physrev.00045.2019
37. Woo K, Sibbald RG, Fogh K, et al. Persistent wound pain. Adv Skin Wound Care. 2021;34:1-14.
38. Ffrench C, Finn D, Velligna A, et al. Systematic review of topical interventions for the management of pain in chronic wounds. Pain Rep. 2023;8(5). doi: 10.1097/PR9.0000000000001073
Article Sidebar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.